Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

NYSE:BX - New York Stock Exchange, Inc. - US09260D1072 - Common Stock - Currency: USD

168.91  +1.27 (+0.76%)

After market: 169.5 +0.59 (+0.35%)

Fundamental Rating

5

Taking everything into account, BX scores 5 out of 10 in our fundamental rating. BX was compared to 237 industry peers in the Capital Markets industry. BX has an excellent profitability rating, but there are concerns on its financial health. BX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year BX was profitable.
BX had a positive operating cash flow in the past year.
BX had positive earnings in each of the past 5 years.
BX had a positive operating cash flow in each of the past 5 years.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

The Return On Assets of BX (5.62%) is better than 74.26% of its industry peers.
BX has a Return On Equity of 31.89%. This is amongst the best in the industry. BX outperforms 96.62% of its industry peers.
BX has a Return On Invested Capital of 16.42%. This is amongst the best in the industry. BX outperforms 91.56% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BX is above the industry average of 7.83%.
The last Return On Invested Capital (16.42%) for BX is above the 3 year average (12.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.62%
ROE 31.89%
ROIC 16.42%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

Looking at the Profit Margin, with a value of 19.83%, BX is in line with its industry, outperforming 59.07% of the companies in the same industry.
BX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 49.58%, BX belongs to the top of the industry, outperforming 85.23% of the companies in the same industry.
In the last couple of years the Operating Margin of BX has remained more or less at the same level.
Industry RankSector Rank
OM 49.58%
PM (TTM) 19.83%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, BX has more shares outstanding
The number of shares outstanding for BX has been increased compared to 5 years ago.
Compared to 1 year ago, BX has an improved debt to assets ratio.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 3.98 indicates that BX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.98, BX belongs to the best of the industry, outperforming 81.86% of the companies in the same industry.
BX has a debt to FCF ratio of 3.48. This is a good value and a sign of high solvency as BX would need 3.48 years to pay back of all of its debts.
BX has a Debt to FCF ratio of 3.48. This is in the better half of the industry: BX outperforms 73.84% of its industry peers.
BX has a Debt/Equity ratio of 1.56. This is a high value indicating a heavy dependency on external financing.
BX has a Debt to Equity ratio of 1.56. This is in the lower half of the industry: BX underperforms 74.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 3.48
Altman-Z 3.98
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.71 indicates that BX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.71, BX is doing worse than 67.93% of the companies in the same industry.
BX has a Quick Ratio of 0.71. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BX (0.71) is worse than 67.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.31% over the past year.
The Earnings Per Share has been growing by 14.97% on average over the past years. This is quite good.
The Revenue has grown by 33.33% in the past year. This is a very strong growth!
The Revenue has been growing by 12.51% on average over the past years. This is quite good.
EPS 1Y (TTM)25.31%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%26.04%
Revenue 1Y (TTM)33.33%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%22.18%

3.2 Future

The Earnings Per Share is expected to grow by 12.53% on average over the next years. This is quite good.
Based on estimates for the next years, BX will show a quite strong growth in Revenue. The Revenue will grow by 15.92% on average per year.
EPS Next Y7.8%
EPS Next 2Y19.25%
EPS Next 3Y21.34%
EPS Next 5Y12.53%
Revenue Next Year9.08%
Revenue Next 2Y17.87%
Revenue Next 3Y19.72%
Revenue Next 5Y15.92%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.78 indicates a quite expensive valuation of BX.
Based on the Price/Earnings ratio, BX is valued a bit more expensive than the industry average as 72.57% of the companies are valued more cheaply.
BX is valuated rather expensively when we compare the Price/Earnings ratio to 26.48, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 25.60, the valuation of BX can be described as expensive.
64.98% of the companies in the same industry are cheaper than BX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 34.04. BX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 33.78
Fwd PE 25.6
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

64.14% of the companies in the same industry are more expensive than BX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 57.72
EV/EBITDA 33.69
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BX may justify a higher PE ratio.
A more expensive valuation may be justified as BX's earnings are expected to grow with 21.34% in the coming years.
PEG (NY)4.33
PEG (5Y)2.26
EPS Next 2Y19.25%
EPS Next 3Y21.34%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.46%, BX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 8.19, BX has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.39, BX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.46%

5.2 History

The dividend of BX is nicely growing with an annual growth rate of 11.16%!
BX has been paying a dividend for at least 10 years, so it has a reliable track record.
BX has decreased its dividend recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

200.72% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
BX's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP200.72%
EPS Next 2Y19.25%
EPS Next 3Y21.34%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (8/8/2025, 8:22:03 PM)

After market: 169.5 +0.59 (+0.35%)

168.91

+1.27 (+0.76%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-15 2025-10-15/amc
Inst Owners70.15%
Inst Owner Change13.07%
Ins Owners0.82%
Ins Owner Change5.68%
Market Cap206.51B
Analysts76.77
Price Target184.58 (9.28%)
Short Float %1.97%
Short Ratio3.82
Dividend
Industry RankSector Rank
Dividend Yield 2.46%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP200.72%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-04 2025-08-04 (1.03)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.54%
Min EPS beat(2)0.65%
Max EPS beat(2)12.43%
EPS beat(4)3
Avg EPS beat(4)3.56%
Min EPS beat(4)-5.35%
Max EPS beat(4)12.43%
EPS beat(8)4
Avg EPS beat(8)1.84%
EPS beat(12)7
Avg EPS beat(12)2.31%
EPS beat(16)11
Avg EPS beat(16)8.06%
Revenue beat(2)1
Avg Revenue beat(2)2.32%
Min Revenue beat(2)-0.22%
Max Revenue beat(2)4.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-6.69%
Max Revenue beat(4)4.86%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)1
Avg Revenue beat(12)-21.14%
Revenue beat(16)5
Avg Revenue beat(16)18.31%
PT rev (1m)19.16%
PT rev (3m)21.41%
EPS NQ rev (1m)1.3%
EPS NQ rev (3m)2.12%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.78%
Revenue NQ rev (1m)0.45%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)2.35%
Revenue NY rev (3m)1.47%
Valuation
Industry RankSector Rank
PE 33.78
Fwd PE 25.6
P/S 16.09
P/FCF 57.72
P/OCF 56.56
P/B 25.89
P/tB 34.82
EV/EBITDA 33.69
EPS(TTM)5
EY2.96%
EPS(NY)6.6
Fwd EY3.91%
FCF(TTM)2.93
FCFY1.73%
OCF(TTM)2.99
OCFY1.77%
SpS10.5
BVpS6.53
TBVpS4.85
PEG (NY)4.33
PEG (5Y)2.26
Profitability
Industry RankSector Rank
ROA 5.62%
ROE 31.89%
ROCE 19.68%
ROIC 16.42%
ROICexc 18.35%
ROICexgc 19.92%
OM 49.58%
PM (TTM) 19.83%
GM N/A
FCFM 27.89%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexcg growth 3Y-21.19%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 3.48
Debt/EBITDA 1.95
Cap/Depr 202.82%
Cap/Sales 0.57%
Interest Coverage 14.9
Cash Conversion 57.07%
Profit Quality 140.65%
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z 3.98
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)25.31%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%26.04%
EPS Next Y7.8%
EPS Next 2Y19.25%
EPS Next 3Y21.34%
EPS Next 5Y12.53%
Revenue 1Y (TTM)33.33%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%22.18%
Revenue Next Year9.08%
Revenue Next 2Y17.87%
Revenue Next 3Y19.72%
Revenue Next 5Y15.92%
EBIT growth 1Y22.76%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year9.21%
EBIT Next 3Y22.86%
EBIT Next 5Y6.22%
FCF growth 1Y-3.07%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-7.35%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%